Stevens Capital Management’s Integra LifeSciences IART Stock Holding History

Stevens Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,412	Closed	-$325K	–	695
2019 Q3	$325K	Sell	5,412 -13,393	-71%	-$798K	0.03%	441
2019 Q2	$1.05M	Sell	18,805 -6,554	-26%	-$338K	0.05%	359
2019 Q1	$1.41M	Buy	+25,359	New	+$1.29M	0.06%	329
2018 Q1	–	Sell	-7,114	Closed	-$340K	–	849
2017 Q4	$340K	Sell	7,114 -5,711	-45%	-$280K	0.01%	636
2017 Q3	$647K	Buy	+12,825	New	+$659K	0.02%	505
2017 Q2	–	Sell	-37,479	Closed	-$1.58M	–	942
2017 Q1	$1.58M	Buy	+37,479	New	+$1.6M	0.06%	343
2016 Q4	–	Sell	-51,372	Closed	-$2.12M	–	979
2016 Q3	$2.12M	Buy	51,372 +43,988	+596%	+$1.84M	0.09%	274
2016 Q2	$295K	Buy	+7,384	New	+$266K	0.01%	687
2015 Q3	–	Sell	-8,822	Closed	-$243K	–	1083
2015 Q2	$243K	Sell	8,822 -6,035	-41%	-$161K	0.01%	808
2015 Q1	$374K	Buy	+14,857	New	+$351K	0.01%	664
2014 Q2	–	Sell	-27,263	Closed	-$513K	–	1161
2014 Q1	$513K	Buy	27,263 +13,514	+98%	+$261K	0.01%	656
2013 Q4	$268K	Buy	+13,749	New	+$252K	0.01%	816

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Stevens Capital Management's IART Position: Q4 2019 in Review

Stevens Capital Management sold out of Integra LifeSciences (IART) in Q4 2019, closing a stake of 5,412 shares — an estimated $325K sold.

Stevens Capital Management first reported a position in IART in Q4 2013 and held it in 12 quarters. The position peaked at $2.12M in Q3 2016. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

Stevens Capital Management reported no remaining Integra LifeSciences position as of Q4 2019 after selling out during the quarter.
Stevens Capital Management sold 5,412 Integra LifeSciences shares in Q4 2019, an estimated $325K.
Stevens Capital Management first reported a position in Integra LifeSciences in Q4 2013 and held it in 12 quarters.
Stevens Capital Management's Integra LifeSciences position peaked at $2.12M in Q3 2016.
279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on Stevens Capital Management's 13F filing for Q4 2019, filed 6 Feb 2020.